Scott Randal W. - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 17, 2025, Scott Randal W.'s relationship to BridgeBio Pharma, Inc. (BBIO) is Director, and currently has 21,589 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BBIO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Scott Randal W. - Insider Non-Derivative Transactions of BBIO Common Stock

Scott Randal W. - Insider Non-Derivative Transactions at BBIO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 18, 2025	Sell -- (Common Stock)	6199	66.89	11589
Nov 18, 2025	Sell -- (Common Stock)	3801	66.25	17788
Nov 18, 2025	M -- (Common Stock)	10000	16.75	21589
Jun 21, 2025	Acquisition -- (Common Stock)	6589	0	11589
Jun 5, 2024	Sell -- (Common Stock)	1500	31.3	4000
Jun 4, 2024	Sell -- (Common Stock)	200	29.48	5500
Jun 4, 2024	Sell -- (Common Stock)	800	28.68	5700
Mar 2, 2024	Sell -- (Common Stock)	2500	34	6500
Dec 19, 2023	Sell -- (Common Stock)	2000	40	9000
Dec 2, 2023	Sell -- (Common Stock)	1500	30	11000
Dec 2, 2023	Sell -- (Common Stock)	1000	28.5	12500
Sep 6, 2023	Sell -- (Common Stock)	2500	30	13500